‘Living medicine’ created to tackle drug-resistant lung infections
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria whic1
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria whic1
Some of the most common side effects of chemotherapy are fatigue, nausea and vomiting. To alleviate them, you should rest, stay hydrated and maintain1
On Tuesday, 17 January 2023, the IDIBAPS auditorium was the venue for the Second Conference on Good Practice of the Network of Tumour Banks of Catalo1
Neurosurgery is a very complex specialty that requires constant study and dedication to perfect the surgical technique. It is a constantly evolving1
Endowed with eight million euros, the project is coordinated by Susana Puig, the head of the research group IDIBAPS Melanoma: imaging, genetics and i1
The MITMEVA project led by the Hospital Clínic Barcelona Cardiovascular Institute has included patient number 100 with aortic valve stenosis (AVS). T1
In addition to the services, the Hospital Clínic Barcelona was recognized as the second-best hospital in Spain and the best in Catalonia. At this eve1
Gene therapy applied to the treatment of neurodegenerative diseases is a promising field of study, and consists of modifying a patient's genes to slo1
It originated in October last year in the US and could become the dominant variant.
IDIBAPS’s Board of Governors has approved the promotion of Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes from Junior Group Leaders t1